bezafibrate has been researched along with 1-anilino-8-naphthalenesulfonate in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arad, R; Bar-Tana, J; Brandes, R | 1 |
| Eisenberg, S; Fainaru, M; Gavish, D; Oschry, Y | 1 |
| Eisenberg, S | 1 |
| Harvengt, C; Heller, F | 1 |
| Fukamachi, I; Hashimoto, H; Kobayashi, J; Niihara, K; Saito, Y; Sasaki, N; Shirai, K; Takahashi, K; Tashiro, J; Yoshida, S | 1 |
| Mori, M; Nagai, T; Nakajima, K; Nakano, T; Saito, T; Tomizawa, T | 1 |
| Friedman, M; Gilhar, D; Hoffman, A; Lomnicky, Y; Luria, MH | 1 |
| Inano, K; Kashiwa, T; Miida, T; Murakami, T; Nakamura, Y; Okada, M; Ozaki, K; Sakai, K; Tsuda, T; Yamaguchi, T | 1 |
| Arístegui, R; Artieda, M; Cenarro, A; Civeira, F; Díaz, C; Gañán, A; Gonzalvo, C; Meriño-Ibarra, E; Pocoví, M; Sol, JM | 1 |
| Bilet, L; Bosma, M; Havekes, B; Hesselink, MK; Hoeks, J; Janssen, MC; Jorgensen, J; Paglialunga, S; Sauerwein, H; Schaart, G; Schrauwen, P; Schrauwen-Hinderling, VB; Smeets, JL; Sparks, L; van de Weijer, T; Wildberger, J; Zechner, R | 1 |
| Hoshina, M; Karahashi, M; Kawashima, Y; Kudo, N; Mitsumoto, A; Sakamoto, T; Yamazaki, T | 1 |
1 trial(s) available for bezafibrate and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.
Topics: Adult; Aged; Atorvastatin; Bezafibrate; Cytosine; Female; Genetic Variation; Genotype; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipids; Lipoproteins; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Pyrroles; Reference Values; Thymine | 2005 |
10 other study(ies) available for bezafibrate and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Adipose conversion of cultured rat primary preadipocytes by hypolipidemic drugs.
Topics: Adipose Tissue; Animals; Bezafibrate; Bucladesine; Cell Differentiation; Cells, Cultured; Clofibrate; Cyclic AMP; Glycerolphosphate Dehydrogenase; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Male; Rats; Triglycerides | 1986 |
Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia.
Topics: Adult; Aged; Apolipoproteins; Bezafibrate; Cholesterol; Cholesterol, LDL; Female; Humans; Hyperlipoproteinemia Type II; Lipase; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides | 1986 |
Hypertriglyceridemia and atherosclerosis analysis of an abnormal lipoprotein system and potential beneficial effects of triglyceride lowering therapy.
Topics: Arteriosclerosis; Bezafibrate; Carrier Proteins; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Humans; Lipase; Lipoprotein Lipase; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides | 1985 |
Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.
Topics: Adult; Bezafibrate; Cholesterol; Clofibrate; Fenofibrate; Humans; Hypolipidemic Agents; Lipase; Lipolysis; Lipoprotein Lipase; Male; Phosphatidylcholine-Sterol O-Acyltransferase; Probucol; Triglycerides | 1983 |
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Topics: Adult; Aged; Bezafibrate; Blood Glucose; Female; Glucose Intolerance; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Immunoenzyme Techniques; Insulin; Lipase; Lipoprotein Lipase; Liver; Male; Middle Aged; Triglycerides | 1994 |
Familial type V hyperlipoproteinemia with hyper-remnant-like particle-cholesterol accompanied with apolipoprotein E3/E4 phenotype.
Topics: Adult; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Bezafibrate; Cholesterol; Chylomicrons; Female; Heparin; Humans; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins, VLDL; Male; Phenotype; Triglycerides | 1996 |
Improved lipid lowering activity of bezafibrate following continuous gastrointestinal administration: pharmacodynamic rationale for sustained release preparation of the drug.
Topics: Animals; Bezafibrate; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Delayed-Action Preparations; Disease Models, Animal; Drug Administration Routes; Duodenum; Enzyme Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipids; Lipoproteins, HDL; Male; Polyethylene Glycols; Rats; Rats, Inbred Lew; Surface-Active Agents | 1999 |
Bezafibrate increases prebeta 1-HDL at the expense of HDL2b in hypertriglyceridemia.
Topics: Adult; Bezafibrate; Carrier Proteins; Cholesterol Ester Transfer Proteins; Enzyme Activation; Female; Glycoproteins; High-Density Lipoproteins, Pre-beta; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipase; Lipoproteins, HDL; Lipoproteins, HDL2; Male; Middle Aged; Molecular Weight; Phosphatidylcholine-Sterol O-Acyltransferase; Triglycerides | 2000 |
Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy.
Topics: Adult; Alleles; Bezafibrate; Fatty Acids; Female; Humans; Hypolipidemic Agents; Lipase; Lipid Metabolism; Lipid Metabolism, Inborn Errors; Muscular Diseases; Mutation; Treatment Outcome | 2013 |
Fibrates reduce triacylglycerol content by upregulating adipose triglyceride lipase in the liver of rats.
Topics: Animals; Bezafibrate; Clofibric Acid; Fatty Liver; Fenofibrate; Lipase; Lipid Peroxidation; Liver; Male; Molecular Targeted Therapy; PPAR alpha; Rats; Rats, Wistar; Triglycerides; Up-Regulation | 2013 |